COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada-Reference-Cited by-同舟云学术

COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada

Published:2023-04 Issue: Volume:20 Page:100461
ISSN:2667-193X
Container-title:The Lancet Regional Health - Americas
language:en
Short-container-title:The Lancet Regional Health - Americas

Author:

Bahremand Taraneh^ORCID,Yao Jiayun Angela,Mill Christopher,Piszczek Jolanta,Grant Jennifer M.^ORCID,Smolina Kate^ORCID

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Internal Medicine,Health Policy

Reference18 articles.

1. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study;Nyberg;Lancet,2022

2. BC COVID-19 data,2022

3. Target product profile analysis of COVID-19 vaccines in phase III clinical trials and beyond: an early 2021 perspective;Funk;Viruses,2021

4. Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden;Nordström;Lancet,2022

5. Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression;Prendecki;Ann Rheum Dis,2021

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine;Vaccine;2024-09

2. Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19;Blood Advances;2024-08-01

3. AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults;Science Translational Medicine;2024-06-26

4. Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network—The VISAGE Study;Vaccines;2024-06-07

5. A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals;The Journal of Infectious Diseases;2024-06-06